1、 BAUD D, DIMOPOULOU AGRI V, GIBSON G R, et al. Using probiotics to flatten the curve of coronavirus disease COVID-2019 pandemic[J]. Front Public Health, 2020(8): 186. BAUD D, DIMOPOULOU AGRI V, GIBSON G R, et al. Using probiotics to flatten the curve of coronavirus disease COVID-2019 pandemic[J]. Front Public Health, 2020(8): 186.
2、 RASTOGI A, BHANSALI A, KHARE N, et al. Short term, high-dose vitamin D supplementation for COVID-19 disease: a randomised, placebo-controlled, study (SHADE study)[J]. Postgrad Med J, 2022, 98(1156): 87-90. RASTOGI A, BHANSALI A, KHARE N, et al. Short term, high-dose vitamin D supplementation for COVID-19 disease: a randomised, placebo-controlled, study (SHADE study)[J]. Postgrad Med J, 2022, 98(1156): 87-90.
3、 NETEA M G, DOMíNGUEZ-ANDRéS J, BARREIRO L B, et al. Defining trained immunity and its role in health and disease[J]. Nat Rev Immunol, 2020, 20(6): 375-388. NETEA M G, DOMíNGUEZ-ANDRéS J, BARREIRO L B, et al. Defining trained immunity and its role in health and disease[J]. Nat Rev Immunol, 2020, 20(6): 375-388.
4、 GALLAGHER-ALLRED C R, VOSS A C, FINN S C, et al. Malnutrition and clinical outcomes: the case for medical nutrition therapy[J]. J Am Diet Assoc, 1996, 96(4):361-366, 369; quiz 367-368. GALLAGHER-ALLRED C R, VOSS A C, FINN S C, et al. Malnutrition and clinical outcomes: the case for medical nutrition therapy[J]. J Am Diet Assoc, 1996, 96(4):361-366, 369; quiz 367-368.
5、 BASTARD P, ROSEN L B, ZHANG Q, et al. Autoantibodies against type I IFNs in patients with life-threatening COVID-19[J]. Science, 2020, 370(6515):eabd4585. BASTARD P, ROSEN L B, ZHANG Q, et al. Autoantibodies against type I IFNs in patients with life-threatening COVID-19[J]. Science, 2020, 370(6515):eabd4585.
6、 ANTONELLI M, PENFOLD R S, MERINO J, et al. Risk factors and disease profile of post-vaccination SARS-CoV-2 infection in UK users of the COVID Symptom Study app: a prospective, community-based, nested, case-control study[J]. Lancet Infect Dis, 2022, 22(1): 43-55. ANTONELLI M, PENFOLD R S, MERINO J, et al. Risk factors and disease profile of post-vaccination SARS-CoV-2 infection in UK users of the COVID Symptom Study app: a prospective, community-based, nested, case-control study[J]. Lancet Infect Dis, 2022, 22(1): 43-55.
7、 KOC H C, XIAO J, LIU W, et al. Long COVID and its management[J]. Int J Biol Sci, 2022, 18(12): 4768-4780. KOC H C, XIAO J, LIU W, et al. Long COVID and its management[J]. Int J Biol Sci, 2022, 18(12): 4768-4780.
8、 COVID-19 rapid guideline: managing the long-term effects of COVID-19[M]. London: National Institute for Health and Care Excellence (NICE), 2020. COVID-19 rapid guideline: managing the long-term effects of COVID-19[M]. London: National Institute for Health and Care Excellence (NICE), 2020.
9、 LIU D, AHMET A, WARD L, et al. A practical guide to the monitoring and management of the complications of systemic corticosteroid therapy[J]. Allergy Asthma Clin Immunol, 2013, 9(1): 30. LIU D, AHMET A, WARD L, et al. A practical guide to the monitoring and management of the complications of systemic corticosteroid therapy[J]. Allergy Asthma Clin Immunol, 2013, 9(1): 30.
10、 LIU Q, MAK J W Y, SU Q, et al. Gut microbiota dynamics in a prospective cohort of patients with post-acute COVID-19 syndrome[J]. Gut, 2022, 71(3): 544-552. LIU Q, MAK J W Y, SU Q, et al. Gut microbiota dynamics in a prospective cohort of patients with post-acute COVID-19 syndrome[J]. Gut, 2022, 71(3): 544-552.
11、 CARFì A, BERNABEI R, LANDI F. Persistent symptoms in patients after acute COVID-19[J]. JAMA, 2020, 324(6): 603-605. CARFì A, BERNABEI R, LANDI F. Persistent symptoms in patients after acute COVID-19[J]. JAMA, 2020, 324(6): 603-605.
12、 GODEAU D, PETIT A, RICHARD I, et al. Return-to-work, disabilities and occupational health in the age of COVID-19[J]. Scand J Work Environ Health, 2021, 47(5): 408-409. GODEAU D, PETIT A, RICHARD I, et al. Return-to-work, disabilities and occupational health in the age of COVID-19[J]. Scand J Work Environ Health, 2021, 47(5): 408-409.
13、 DANI M, DIRKSEN A, TARABORRELLI P, et al. Autonomic dysfunction in ‘long COVID’: rationale, physiology and management strategies[J]. Clin Med (Lond), 2021, 21(1): e63-e67. DANI M, DIRKSEN A, TARABORRELLI P, et al. Autonomic dysfunction in ‘long COVID’: rationale, physiology and management strategies[J]. Clin Med (Lond), 2021, 21(1): e63-e67.
14、 GOLDSTEIN D S. The possible association between COVID-19 and postural tachycardia syndrome[J]. Heart Rhythm, 2021, 18(4): 508-509. GOLDSTEIN D S. The possible association between COVID-19 and postural tachycardia syndrome[J]. Heart Rhythm, 2021, 18(4): 508-509.
15、 TAQUET M, GEDDES J R, HUSAIN M, et al. 6-month neurological and psychiatric outcomes in 236-379 survivors of COVID-19: a retrospective cohort study using electronic health records[J]. Lancet Psychiatry, 2021, 8(5): 416-427. TAQUET M, GEDDES J R, HUSAIN M, et al. 6-month neurological and psychiatric outcomes in 236-379 survivors of COVID-19: a retrospective cohort study using electronic health records[J]. Lancet Psychiatry, 2021, 8(5): 416-427.
16、 DOUAUD G, LEE S, ALFARO-ALMAGRO F, et al. SARS-CoV-2 is associated with changes in brain structure in UK Biobank[J]. Nature, 2022, 604(7907):697-707. DOUAUD G, LEE S, ALFARO-ALMAGRO F, et al. SARS-CoV-2 is associated with changes in brain structure in UK Biobank[J]. Nature, 2022, 604(7907):697-707.
17、 HOSP J A, DRESSING A, BLAZHENETS G, et al. Cognitive impairment and altered cerebral glucose metabolism in the subacute stage of COVID-19[J]. BRAIN, 2021, 144(4): 1263-1276. HOSP J A, DRESSING A, BLAZHENETS G, et al. Cognitive impairment and altered cerebral glucose metabolism in the subacute stage of COVID-19[J]. BRAIN, 2021, 144(4): 1263-1276.
18、 DAVIS H E, ASSAF G S, MCCORKELL L, et al. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact[J]. E Clin Med, 2021(38): 101019. DAVIS H E, ASSAF G S, MCCORKELL L, et al. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact[J]. E Clin Med, 2021(38): 101019.
19、 CROOK H, RAZA S, NOWELL J, et al. Long covid-mechanisms, risk factors, and management[J]. BMJ, 2021(374): n1648. CROOK H, RAZA S, NOWELL J, et al. Long covid-mechanisms, risk factors, and management[J]. BMJ, 2021(374): n1648.
20、 ZAREI M, BOSE D, NOURI-VASKEH M, et al. Long-term side effects and lingering symptoms post COVID-19 recovery[J]. Rev Med Virol, 2022, 32(3): e2289. ZAREI M, BOSE D, NOURI-VASKEH M, et al. Long-term side effects and lingering symptoms post COVID-19 recovery[J]. Rev Med Virol, 2022, 32(3): e2289.
21、 MANDAL S, BARNETT J, BRILL S E, et al. ‘Long-COVID’: a cross-sectional study of persisting symptoms, biomarker and imaging abnormalities following hospitalisation for COVID-19[J]. Thorax, 2021, 76(4): 396-398. MANDAL S, BARNETT J, BRILL S E, et al. ‘Long-COVID’: a cross-sectional study of persisting symptoms, biomarker and imaging abnormalities following hospitalisation for COVID-19[J]. Thorax, 2021, 76(4): 396-398.
22、 de BIASE S, COOK L, SKELTON D A, et al. The COVID-19 rehabilitation pandemic[J]. Age Ageing, 2020, 49(5): 696-700. de BIASE S, COOK L, SKELTON D A, et al. The COVID-19 rehabilitation pandemic[J]. Age Ageing, 2020, 49(5): 696-700.
23、 SORIANO J B, MURTHY S, MARSHALL J C, et al. A clinical case definition of post-COVID-19 condition by a Delphi consensus[J]. Lancet Infect Dis, 2022, 22(4): e102-e107. SORIANO J B, MURTHY S, MARSHALL J C, et al. A clinical case definition of post-COVID-19 condition by a Delphi consensus[J]. Lancet Infect Dis, 2022, 22(4): e102-e107.
24、 DAITCH V, YELIN D, AWWAD M, et al. Characteristics of long-COVID among older adults: a cross-sectional study[J]. Int J Infect Dis, 2022(125): 287-293. DAITCH V, YELIN D, AWWAD M, et al. Characteristics of long-COVID among older adults: a cross-sectional study[J]. Int J Infect Dis, 2022(125): 287-293.
25、 GOLINO A J, LEONE R, GOLLENBERG A, et al. Impact of an active music therapy intervention on intensive care patients[J]. Am J Crit Care, 2019, 28(1): 48-55. GOLINO A J, LEONE R, GOLLENBERG A, et al. Impact of an active music therapy intervention on intensive care patients[J]. Am J Crit Care, 2019, 28(1): 48-55.
26、 KIEKENS C, BOLDRINI P, ANDREOLI A, et al. Rehabilitation and respiratory management in the acute and early post-acute phase. “Instant paper from the field” on rehabilitation answers to the COVID-19 emergency[J]. Eur J Phys Rehabil Med, 2020, 56(3): 323-326. KIEKENS C, BOLDRINI P, ANDREOLI A, et al. Rehabilitation and respiratory management in the acute and early post-acute phase. “Instant paper from the field” on rehabilitation answers to the COVID-19 emergency[J]. Eur J Phys Rehabil Med, 2020, 56(3): 323-326.
27、 YOHANNES A M. COPD patients in a COVID-19 society: depression and anxiety[J]. Expert Rev Respir Med, 2021, 15(1): 5-7. YOHANNES A M. COPD patients in a COVID-19 society: depression and anxiety[J]. Expert Rev Respir Med, 2021, 15(1): 5-7.
28、 刘绛云,胡星星,郭立中. 超声指导穴位电刺激对机械通气相关膈肌功能障碍的影响[J]. 中国针灸, 2019, 39(9): 913-917. 刘绛云,胡星星,郭立中. 超声指导穴位电刺激对机械通气相关膈肌功能障碍的影响[J]. 中国针灸, 2019, 39(9): 913-917.
29、 中国康复医学会,中国康复医学会呼吸康复专委会,中华医学会物理医学与康复学分会心肺康复学组. 2019新型冠状病毒肺炎呼吸康复指导意见(第二版)[J]. 中华结核和呼吸杂志, 2020, 43(4):308-314. 中国康复医学会,中国康复医学会呼吸康复专委会,中华医学会物理医学与康复学分会心肺康复学组. 2019新型冠状病毒肺炎呼吸康复指导意见(第二版)[J]. 中华结核和呼吸杂志, 2020, 43(4):308-314.
30、 SUN T, GUO L, TIAN F, et al. Rehabilitation of patients with COVID-19[J]. Expert Rev Respir Med, 2020, 14(12): 1249-1256. SUN T, GUO L, TIAN F, et al. Rehabilitation of patients with COVID-19[J]. Expert Rev Respir Med, 2020, 14(12): 1249-1256.
31、 ZHAO H M, XIE Y X, WANG C. Recommendations for respiratory rehabilitation in adults with coronavirus disease 2019[J]. Chin Med J (Engl), 2020, 133(13): 1595-1602. ZHAO H M, XIE Y X, WANG C. Recommendations for respiratory rehabilitation in adults with coronavirus disease 2019[J]. Chin Med J (Engl), 2020, 133(13): 1595-1602.
32、 SPRUIT M A. Pulmonary rehabilitation[J]. Eur Respir Rev, 2014, 23(131): 55-63. SPRUIT M A. Pulmonary rehabilitation[J]. Eur Respir Rev, 2014, 23(131): 55-63.
33、 BARKER-DAVIES R M, O'SULLIVAN O, SENARATNE K P P, et al. The Stanford Hall consensus statement for post-COVID-19 rehabilitation[J]. Br J Sports Med, 2020, 54(16): 949-959. BARKER-DAVIES R M, O'SULLIVAN O, SENARATNE K P P, et al. The Stanford Hall consensus statement for post-COVID-19 rehabilitation[J]. Br J Sports Med, 2020, 54(16): 949-959.
34、 中华医学会重症医学分会重症呼吸学组. 急性呼吸窘迫综合征患者俯卧位通气治疗规范化流程[J]. 中华内科杂志, 2020, 59(10): 781-787. 中华医学会重症医学分会重症呼吸学组. 急性呼吸窘迫综合征患者俯卧位通气治疗规范化流程[J]. 中华内科杂志, 2020, 59(10): 781-787.
35、 CHEN S, ZHU Q, XIAO Y, et al. Clinical and etiological analysis of co-infections and secondary infections in COVID-19 patients: An observational study[J]. Clin Respir J, 2021, 15(7): 815-825. CHEN S, ZHU Q, XIAO Y, et al. Clinical and etiological analysis of co-infections and secondary infections in COVID-19 patients: An observational study[J]. Clin Respir J, 2021, 15(7): 815-825.
36、 VAUGHN V M, GANDHI T N, PETTY L A, et al. Empiric Antibacterial Therapy and Community-onset Bacterial Coinfection in Patients Hospitalized With Coronavirus Disease 2019 (COVID-19): A Multi-hospital Cohort Study[J]. Clin Infect Dis, 2021, 72(10): e533-e541. VAUGHN V M, GANDHI T N, PETTY L A, et al. Empiric Antibacterial Therapy and Community-onset Bacterial Coinfection in Patients Hospitalized With Coronavirus Disease 2019 (COVID-19): A Multi-hospital Cohort Study[J]. Clin Infect Dis, 2021, 72(10): e533-e541.
37、 ELABBADI A, TURPIN M, GEROTZIAFAS G T, et al. Bacterial coinfection in critically ill COVID-19 patients with severe pneumonia[J]. Infection, 2021, 49(3): 559-562. ELABBADI A, TURPIN M, GEROTZIAFAS G T, et al. Bacterial coinfection in critically ill COVID-19 patients with severe pneumonia[J]. Infection, 2021, 49(3): 559-562.
38、 WELTE T, DELLINGER R P, EBELT H, et al. Efficacy and safety of trimodulin, a novel polyclonal antibody preparation, in patients with severe community-acquired pneumonia: a randomized, placebo-controlled, double-blind, multicenter, phase II trial (CIGMA study)[J]. Intensive Care Med, 2018, 44(4): 438-448. WELTE T, DELLINGER R P, EBELT H, et al. Efficacy and safety of trimodulin, a novel polyclonal antibody preparation, in patients with severe community-acquired pneumonia: a randomized, placebo-controlled, double-blind, multicenter, phase II trial (CIGMA study)[J]. Intensive Care Med, 2018, 44(4): 438-448.
39、 KINDGEN-MILLES D, FELDT T, JENSEN B E O, et al. Why the application of IVIG might be beneficial in patients with COVID-19[J]. Lancet Respir Med, 2022, 10(2): e15. KINDGEN-MILLES D, FELDT T, JENSEN B E O, et al. Why the application of IVIG might be beneficial in patients with COVID-19[J]. Lancet Respir Med, 2022, 10(2): e15.
40、 陈旭娇,严静,王建业,等. 老年综合评估技术应用中国专家共识[J]. 中华老年医学杂志, 2017, 36(5): 471-477. 陈旭娇,严静,王建业,等. 老年综合评估技术应用中国专家共识[J]. 中华老年医学杂志, 2017, 36(5): 471-477.
41、 YAO J S, DEE E C, MILAZZO C, et al. Covid-19 in dementia: an insidious pandemic[J]. Age Ageing, 2020, 49(5): 713-715. YAO J S, DEE E C, MILAZZO C, et al. Covid-19 in dementia: an insidious pandemic[J]. Age Ageing, 2020, 49(5): 713-715.
42、 IACCARINO G, GRASSI G, BORGHI C, et al. Age and multimorbidity predict death among COVID-19 patients: results of the SARS-RAS study of the Italian society of hypertension[J]. Hypertension, 2020, 76(2): 366-372. IACCARINO G, GRASSI G, BORGHI C, et al. Age and multimorbidity predict death among COVID-19 patients: results of the SARS-RAS study of the Italian society of hypertension[J]. Hypertension, 2020, 76(2): 366-372.
43、 VERONESE N, CUSTODERO C, DEMURTAS J, et al. Comprehensive geriatric assessment in older people: an umbrella review of health outcomes[J]. Age Ageing, 2022, 51(5):afac104. VERONESE N, CUSTODERO C, DEMURTAS J, et al. Comprehensive geriatric assessment in older people: an umbrella review of health outcomes[J]. Age Ageing, 2022, 51(5):afac104.
44、 中华医学会呼吸病学分会危重症学组,中华医学会呼吸病学分会危重症学组. 奥密克戎变异株所致重症新型冠状病毒感染临床救治专家推荐意见[J]. 中华结核和呼吸杂志, 2023, 46(2). 中华医学会呼吸病学分会危重症学组,中华医学会呼吸病学分会危重症学组. 奥密克戎变异株所致重症新型冠状病毒感染临床救治专家推荐意见[J]. 中华结核和呼吸杂志, 2023, 46(2).
45、 SIMONSON T S, BAKER T L, BANZETT R B, et al. Silent hypoxaemia in COVID-19 patients[J]. J Physiol, 2021, 599(4): 1057-1065. SIMONSON T S, BAKER T L, BANZETT R B, et al. Silent hypoxaemia in COVID-19 patients[J]. J Physiol, 2021, 599(4): 1057-1065.
46、 UNIM B, PALMIERI L, LO NOCE C, et al. Prevalence of COVID-19-related symptoms by age group[J]. Aging Clin Exp Res,2021, 33(4): 1145-1147. UNIM B, PALMIERI L, LO NOCE C, et al. Prevalence of COVID-19-related symptoms by age group[J]. Aging Clin Exp Res,2021, 33(4): 1145-1147.
47、 CLIFFORD C T, POUR T R, FREEMAN R, et al. Association between COVID-19 diagnosis and presenting chief complaint from New York City triage data[J]. Am J Emerg Med,2021(46): 520-524. CLIFFORD C T, POUR T R, FREEMAN R, et al. Association between COVID-19 diagnosis and presenting chief complaint from New York City triage data[J]. Am J Emerg Med,2021(46): 520-524.
48、 O'HANLON S, INOUYE S K. Delirium: a missing piece in the COVID-19 pandemic puzzle[J]. Age Ageing,2020, 49(4): 497-498. O'HANLON S, INOUYE S K. Delirium: a missing piece in the COVID-19 pandemic puzzle[J]. Age Ageing,2020, 49(4): 497-498.
49、 GUAN W J, NI Z Y, HU Y, et al. Clinical Characteristics of Coronavirus Disease 2019 in China[J]. N Engl J Med,2020, 382(18): 1708-1720. GUAN W J, NI Z Y, HU Y, et al. Clinical Characteristics of Coronavirus Disease 2019 in China[J]. N Engl J Med,2020, 382(18): 1708-1720.
50、 KARIYAWASAM J C, JAYARAJAH U, RIZA R, et al. Gastrointestinal manifestations in COVID-19[J]. Trans R Soc Trop Med Hyg,2021, 115(12): 1362-1388. KARIYAWASAM J C, JAYARAJAH U, RIZA R, et al. Gastrointestinal manifestations in COVID-19[J]. Trans R Soc Trop Med Hyg,2021, 115(12): 1362-1388.
51、 DONNELLY C A, GHANI A C, LEUNG G M, et al. Epidemiological determinants of spread of causal agent of severe acute respiratory syndrome in Hong Kong[J]. Lancet,2003, 361(9371): 1761-1766. DONNELLY C A, GHANI A C, LEUNG G M, et al. Epidemiological determinants of spread of causal agent of severe acute respiratory syndrome in Hong Kong[J]. Lancet,2003, 361(9371): 1761-1766.
52、 YUKI K, FUJIOGI M, KOUTSOGIANNAKI S. COVID-19 pathophysiology: A review[J]. Clin Immunol, 2020(215): 108427. YUKI K, FUJIOGI M, KOUTSOGIANNAKI S. COVID-19 pathophysiology: A review[J]. Clin Immunol, 2020(215): 108427.
53、 中华人民共和国国家卫生健康委员会. 新型冠状病毒感染诊疗方案(第十版)[J]. 中华临床感染病杂志, 2023(16): 1-9. 中华人民共和国国家卫生健康委员会. 新型冠状病毒感染诊疗方案(第十版)[J]. 中华临床感染病杂志, 2023(16): 1-9.
